15.37USD0.00%Mkt Cap: 307.53M USDP/E: —Last update: 2026-05-26
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwid…
Industry Peers
Health Information ServicesIndicators:|
Key Statistics
Company
Market Cap307.53M USD
Enterprise Value263.98M USD
Revenue (TTM)80.53M USD
Gross Profit46.22M USD
Net Income (TTM)-64.72M USD
Revenue/Share4.000 USD
Last Price15.37 USD
Fiscal Year EndAug 2025
MR QuarterFeb 2026
Employees212
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)16.39
PEG9.88
EV/EBITDA18.91
EV/Revenue3.28
P/S3.79
P/B2.28
EPS (TTM)-3.12
EPS (Forward)0.92
52W Range
11.0919% of range34.01
52W High34.01 USD
52W Low11.09 USD
Profitability
Gross Margin58.38%
Oper. Margin23.18%
EBITDA Margin17.34%
Profit Margin-81.74%
ROE-51.86%
ROA-49.05%
Growth
Revenue Growth8.30%
Earnings Growth46.70%
Cash Flow & Leverage
Operating CF18.13M USD
CapEx (TTM)3.72M USD
FCF Margin21.33%
FCF Yield5.59%
Net Debt-41.33M USD
Net Debt/EBITDA-2.96
Balance Sheet
Debt/Equity0.00
Current Ratio5.47
Quick Ratio5.26
Book Value/Sh6.621 USD
Cash/Share2.071 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield0.52%
Payout Ratio0.00%
Ex-Div DateJul 29, 2024
Pay DateAug 5, 2024
Splits
Last Split2:1
Split DateOct 2, 2007
Analyst Consensus
Rating—
Target (Mean)23.67 USD
Target Range16.00 USD – 31.00 USD
# Analysts3
Ownership
Shares Out.20.21M
Float16.71M
Insiders17.29%
Institutions83.01%
Short Interest
Short Ratio3.3d
Short % Float9.13%
Short % Out.6.47%
Shares Short1.31M
Short (prev mo.)1.20M
Technical
SMA 5013.51 (+13.8%)
SMA 20015.48 (-0.7%)
Beta1.28
S&P 52W Chg28.31%
Avg Vol (30d)369.26K
Avg Vol (10d)302.26K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—